Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2013

01-02-2013 | Original Article

Attenuation of Acetic Acid-Induced Gastric Ulcer Formation in Rats by Glucosylceramide Synthase Inhibitors

Authors: Manabu Nakashita, Hidekazu Suzuki, Soichiro Miura, Takao Taki, Keita Uehara, Tohru Mizushima, Hiroshi Nagata, Toshifumi Hibi

Published in: Digestive Diseases and Sciences | Issue 2/2013

Login to get access

Abstract

Introduction

Ceramide has been suggested to play a role in apoptosis during gastric ulcerogenesis. The present study is designed to investigate whether accumulated ceramide could serve as the effector molecules of ulcer formation in a rat model of acetic acid-induced gastric ulcer.

Methods

The effect of fumonisin B1, an inhibitor of ceramide synthase, and of d,l,-threo-1-phenyl-2-hexadecanoylamino-3-morpholino-1-propanol (PPMP) and N-butyldeoxynojirimycin (NB-DNJ), both inhibitors of glucosylceramide synthase, on the accumulation of ceramide and formation of gastric ulcer were examined in the rat model of acetic acid-induced gastric ulcer.

Results

Fumonisin B1 attenuated acetic acid-induced gastric ulcer formation, associated with a decrease in the number of apoptotic cells. Our results showed that it is neither the C18- nor the C24-ceramide itself, but the respective metabolites that were ulcerogenic, because PPMP and NB-DNJ attenuated gastric mucosal apoptosis and the consequent mucosal damage in spite of their reducing the degradation of ceramide.

Conclusion

The ceramide pathway, in particular, the metabolites of ceramide, significantly contributes to acetic acid-induced gastric damage, possibly via enhancing apoptosis. On the other hand, PPMP and NB-DNJ treatment attenuated gastric mucosal apoptosis and ulcer formation despite increasing the ceramide accumulation, suggesting that it was not the ceramides themselves, but their metabolites that contributed to the ulcer formation in the acetic acid-induced gastric ulcer model.
Literature
1.
go back to reference Konturek PC, Brzozowski T, Konturek SJ, et al. Apoptosis in gastric mucosa with stress-induced gastric ulcers. J Physiol Pharmacol. 1999;50:211–225.PubMed Konturek PC, Brzozowski T, Konturek SJ, et al. Apoptosis in gastric mucosa with stress-induced gastric ulcers. J Physiol Pharmacol. 1999;50:211–225.PubMed
2.
go back to reference Suzuki H, Ishii H. Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury. J Gastroenterol Hepatol. 2000;15:D46–D54.CrossRefPubMed Suzuki H, Ishii H. Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury. J Gastroenterol Hepatol. 2000;15:D46–D54.CrossRefPubMed
3.
go back to reference Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1–15.CrossRefPubMed Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1–15.CrossRefPubMed
4.
go back to reference Suzuki H, Marshall BJ, Hibi T. Overview: Helicobacter pylori and extragastric disease. Int J Hematol. 2006;84:291–300.CrossRefPubMed Suzuki H, Marshall BJ, Hibi T. Overview: Helicobacter pylori and extragastric disease. Int J Hematol. 2006;84:291–300.CrossRefPubMed
5.
go back to reference Suzuki H, Iwasaki E, Hibi T. Helicobacter pylori and gastric cancer. Gastric Cancer. 2009;12:79–87.CrossRefPubMed Suzuki H, Iwasaki E, Hibi T. Helicobacter pylori and gastric cancer. Gastric Cancer. 2009;12:79–87.CrossRefPubMed
6.
go back to reference Leung WK, To KF, Chan FK, Lee TL, Chung SC, Sung JJ. Interaction of Helicobacter pylori eradication and non-steroidal anti-inflammatory drugs on gastric epithelial apoptosis and proliferation: implications on ulcerogenesis. Aliment Pharmacol Ther. 2000;14:879–885.CrossRefPubMed Leung WK, To KF, Chan FK, Lee TL, Chung SC, Sung JJ. Interaction of Helicobacter pylori eradication and non-steroidal anti-inflammatory drugs on gastric epithelial apoptosis and proliferation: implications on ulcerogenesis. Aliment Pharmacol Ther. 2000;14:879–885.CrossRefPubMed
7.
go back to reference Nagata H, Akiba Y, Suzuki H, Okano H, Hibi T. Expression of Musashi-1 in the rat stomach and changes during mucosal injury and restitution. FEBS Lett. 2006;580:27–33.CrossRefPubMed Nagata H, Akiba Y, Suzuki H, Okano H, Hibi T. Expression of Musashi-1 in the rat stomach and changes during mucosal injury and restitution. FEBS Lett. 2006;580:27–33.CrossRefPubMed
8.
go back to reference Liu ES, Cho CH. Relationship between ethanol-induced gastritis and gastric ulcer formation in rats. Digestion. 2000;62:232–239.CrossRefPubMed Liu ES, Cho CH. Relationship between ethanol-induced gastritis and gastric ulcer formation in rats. Digestion. 2000;62:232–239.CrossRefPubMed
9.
go back to reference Hakomori S, Igarashi Y. Functional role of glycosphingolipids in cell recognition and signaling. J Biochem (Tokyo). 1995;118:1091–1103. Hakomori S, Igarashi Y. Functional role of glycosphingolipids in cell recognition and signaling. J Biochem (Tokyo). 1995;118:1091–1103.
10.
go back to reference Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science. 1996;274:1855–1859.CrossRefPubMed Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science. 1996;274:1855–1859.CrossRefPubMed
11.
go back to reference Tepper AD, Diks SH, van Blitterswijk WJ, Borst J. Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens. J Biol Chem. 2000;275:34810–34817.CrossRefPubMed Tepper AD, Diks SH, van Blitterswijk WJ, Borst J. Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens. J Biol Chem. 2000;275:34810–34817.CrossRefPubMed
12.
go back to reference Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science. 1993;259:1769–1771.CrossRefPubMed Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science. 1993;259:1769–1771.CrossRefPubMed
13.
go back to reference Dbaibo GS, Obeid LM, Hannun YA. Tumor necrosis factor-α (TNF-α) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-α from activation of nuclear factor-kappa B. J Biol Chem. 1993;268:17762–17766.PubMed Dbaibo GS, Obeid LM, Hannun YA. Tumor necrosis factor-α (TNF-α) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-α from activation of nuclear factor-kappa B. J Biol Chem. 1993;268:17762–17766.PubMed
14.
go back to reference Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 1994;77:325–328.CrossRefPubMed Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 1994;77:325–328.CrossRefPubMed
15.
go back to reference Kim MY, Linardic C, Obeid L, Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and γ-interferon. Specific role in cell differentiation. J Biol Chem. 1991;266:484–489.PubMed Kim MY, Linardic C, Obeid L, Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and γ-interferon. Specific role in cell differentiation. J Biol Chem. 1991;266:484–489.PubMed
16.
go back to reference Cifone MG, De Maria R, Roncaioli P, et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med. 1994;180:1547–1552.CrossRefPubMed Cifone MG, De Maria R, Roncaioli P, et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med. 1994;180:1547–1552.CrossRefPubMed
17.
go back to reference Takeuchi T, Miura S, Wang L, et al. Nuclear factor-kappa B and TNF-α mediate gastric ulceration induced by phorbol myristate acetate. Dig Dis Sci. 2002;47:2070–2078.CrossRefPubMed Takeuchi T, Miura S, Wang L, et al. Nuclear factor-kappa B and TNF-α mediate gastric ulceration induced by phorbol myristate acetate. Dig Dis Sci. 2002;47:2070–2078.CrossRefPubMed
18.
go back to reference Uehara K, Miura S, Takeuchi T, et al. Significant role of ceramide pathway in experimental gastric ulcer formation in rats. J Pharmacol Exp Ther. 2003;305:232–239.CrossRefPubMed Uehara K, Miura S, Takeuchi T, et al. Significant role of ceramide pathway in experimental gastric ulcer formation in rats. J Pharmacol Exp Ther. 2003;305:232–239.CrossRefPubMed
19.
go back to reference Koltun E, Richards S, Chan V, et al. Discovery of a new class of glucosylceramide synthase inhibitors. Bioorg Med Chem Lett. 2011;21:6773–6777.CrossRefPubMed Koltun E, Richards S, Chan V, et al. Discovery of a new class of glucosylceramide synthase inhibitors. Bioorg Med Chem Lett. 2011;21:6773–6777.CrossRefPubMed
20.
go back to reference Shayman JA, Lee L, Abe A, Shu L. Inhibitors of glucosylceramide synthase. Methods Enzymol. 2000;311:373–387.CrossRefPubMed Shayman JA, Lee L, Abe A, Shu L. Inhibitors of glucosylceramide synthase. Methods Enzymol. 2000;311:373–387.CrossRefPubMed
21.
go back to reference Platt FM, Neises GR, Karlsson GB, Dwek RA, Butters TD. N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing. J Biol Chem. 1994;269:27108–27114.PubMed Platt FM, Neises GR, Karlsson GB, Dwek RA, Butters TD. N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing. J Biol Chem. 1994;269:27108–27114.PubMed
22.
go back to reference Okabe S, Pfeiffer CJ. Chronicity of acetic acid ulcer in the rat stomach. Am J Dig Dis. 1972;17:619–629.CrossRefPubMed Okabe S, Pfeiffer CJ. Chronicity of acetic acid ulcer in the rat stomach. Am J Dig Dis. 1972;17:619–629.CrossRefPubMed
23.
go back to reference Wang E, Norred WP, Bacon CW, Riley RT, Merrill AH Jr. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem. 1991;266:14486–14490.PubMed Wang E, Norred WP, Bacon CW, Riley RT, Merrill AH Jr. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem. 1991;266:14486–14490.PubMed
24.
go back to reference Berg H, Magard M, Johansson G, Mathiasson L. Development of a supercritical fluid extraction method for determination of lipid classes and total fat in meats and its comparison with conventional methods. J Chromatogr A. 1997;785:345–352.CrossRefPubMed Berg H, Magard M, Johansson G, Mathiasson L. Development of a supercritical fluid extraction method for determination of lipid classes and total fat in meats and its comparison with conventional methods. J Chromatogr A. 1997;785:345–352.CrossRefPubMed
25.
go back to reference Merrill AH Jr, van Echten G, Wang E, Sandhoff K. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J Biol Chem. 1993;268:27299–27306.PubMed Merrill AH Jr, van Echten G, Wang E, Sandhoff K. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J Biol Chem. 1993;268:27299–27306.PubMed
26.
go back to reference Maurer BJ, Melton L, Billups C, Cabot MC, Reynolds CP. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism. J Natl Cancer Inst. 2000;92:1897–1909.CrossRefPubMed Maurer BJ, Melton L, Billups C, Cabot MC, Reynolds CP. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism. J Natl Cancer Inst. 2000;92:1897–1909.CrossRefPubMed
27.
go back to reference Svensson M, Frendeus B, Butters T, Platt F, Dwek R, Svanborg C. Glycolipid depletion in antimicrobial therapy. Mol Microbiol. 2003;47:453–461.CrossRefPubMed Svensson M, Frendeus B, Butters T, Platt F, Dwek R, Svanborg C. Glycolipid depletion in antimicrobial therapy. Mol Microbiol. 2003;47:453–461.CrossRefPubMed
28.
go back to reference Lovat PE, Corazzari M, Di Sano F, Piacentini M, Redfern CP. The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma. Cancer Lett. 2005;228:105–110.CrossRefPubMed Lovat PE, Corazzari M, Di Sano F, Piacentini M, Redfern CP. The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma. Cancer Lett. 2005;228:105–110.CrossRefPubMed
29.
go back to reference Morales A, Colell A, Mari M, Garcia-Ruiz C, Fernandez-Checa JC. Glycosphingolipids and mitochondria: role in apoptosis and disease. Glycoconj J. 2004;20:579–588.CrossRefPubMed Morales A, Colell A, Mari M, Garcia-Ruiz C, Fernandez-Checa JC. Glycosphingolipids and mitochondria: role in apoptosis and disease. Glycoconj J. 2004;20:579–588.CrossRefPubMed
30.
go back to reference Jeckel D, Karrenbauer A, Burger KN, van Meer G, Wieland F. Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J Cell Biol. 1992;117:259–267.CrossRefPubMed Jeckel D, Karrenbauer A, Burger KN, van Meer G, Wieland F. Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J Cell Biol. 1992;117:259–267.CrossRefPubMed
31.
go back to reference Ichikawa S, Hirabayashi Y. Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol. 1998;8:198–202.CrossRefPubMed Ichikawa S, Hirabayashi Y. Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol. 1998;8:198–202.CrossRefPubMed
32.
go back to reference Lavie Y, Cao H, Bursten SL, Giuliano AE, Cabot MC. Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem. 1996;271:19530–19536.CrossRefPubMed Lavie Y, Cao H, Bursten SL, Giuliano AE, Cabot MC. Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem. 1996;271:19530–19536.CrossRefPubMed
33.
go back to reference Liu YY, Han TY, Giuliano AE, Ichikawa S, Hirabayashi Y, Cabot MC. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-α-induced apoptosis. Exp Cell Res. 1999;252:464–470.CrossRefPubMed Liu YY, Han TY, Giuliano AE, Ichikawa S, Hirabayashi Y, Cabot MC. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-α-induced apoptosis. Exp Cell Res. 1999;252:464–470.CrossRefPubMed
34.
go back to reference Kolter T, Proia RL, Sandhoff K. Combinatorial ganglioside biosynthesis. J Biol Chem. 2002;277:25859–25862.CrossRefPubMed Kolter T, Proia RL, Sandhoff K. Combinatorial ganglioside biosynthesis. J Biol Chem. 2002;277:25859–25862.CrossRefPubMed
35.
go back to reference Platt FM, Neises GR, Reinkensmeier G, et al. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science. 1997;276:428–431.CrossRefPubMed Platt FM, Neises GR, Reinkensmeier G, et al. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science. 1997;276:428–431.CrossRefPubMed
36.
go back to reference Platt FM, Reinkensmeier G, Dwek RA, Butters TD. Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycin. J Biol Chem. 1997;272:19365–19372.CrossRefPubMed Platt FM, Reinkensmeier G, Dwek RA, Butters TD. Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycin. J Biol Chem. 1997;272:19365–19372.CrossRefPubMed
37.
go back to reference Cox T, Lachmann R, Hollak C, et al. Novel oral treatment of Gaucher’s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet. 2000;355:1481–1485.CrossRefPubMed Cox T, Lachmann R, Hollak C, et al. Novel oral treatment of Gaucher’s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet. 2000;355:1481–1485.CrossRefPubMed
38.
go back to reference Garcia-Ruiz C, Colell A, Paris R, Fernandez-Checa JC. Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB J. 2000;14:847–858.PubMed Garcia-Ruiz C, Colell A, Paris R, Fernandez-Checa JC. Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB J. 2000;14:847–858.PubMed
39.
go back to reference De Maria R, Lenti L, Malisan F, et al. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science. 1997;277:1652–1655.CrossRefPubMed De Maria R, Lenti L, Malisan F, et al. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science. 1997;277:1652–1655.CrossRefPubMed
40.
go back to reference Colell A, Morales A, Fernandez-Checa JC, Garcia-Ruiz C. Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-α-mediated apoptosis in human colon HT-29 cells through glycosphingolipids formation. Possible role of ganglioside GD3. FEBS Lett. 2002;526:135–141.CrossRefPubMed Colell A, Morales A, Fernandez-Checa JC, Garcia-Ruiz C. Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-α-mediated apoptosis in human colon HT-29 cells through glycosphingolipids formation. Possible role of ganglioside GD3. FEBS Lett. 2002;526:135–141.CrossRefPubMed
41.
go back to reference Garcia-Ruiz C, Colell A, Morales A, Calvo M, Enrich C, Fernandez-Checa JC. Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-α. J Biol Chem. 2002;277:36443–36448.CrossRefPubMed Garcia-Ruiz C, Colell A, Morales A, Calvo M, Enrich C, Fernandez-Checa JC. Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-α. J Biol Chem. 2002;277:36443–36448.CrossRefPubMed
Metadata
Title
Attenuation of Acetic Acid-Induced Gastric Ulcer Formation in Rats by Glucosylceramide Synthase Inhibitors
Authors
Manabu Nakashita
Hidekazu Suzuki
Soichiro Miura
Takao Taki
Keita Uehara
Tohru Mizushima
Hiroshi Nagata
Toshifumi Hibi
Publication date
01-02-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2350-x

Other articles of this Issue 2/2013

Digestive Diseases and Sciences 2/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.